小智港股覆盤 | 5月24日
今日,港股三大指數集體下跌。截止收盤,恆生指數跌1.75%,報20112點。國企指數跌1.98%,報6883點。恆生科技指數大跌3.48%,報4032點。市場約505只個股上漲,1143只個股下跌。成交額突破1136.39億港幣,和昨天同期相比增長8.09%。南下資金淨流入9.17億港幣。

盤面上,海運板塊走高。

CRO板塊全線走低。泰格醫藥跌超8%;方達控股、藥明康德、金斯瑞生物科技等多股跌超6%;昭衍新藥跌超5%。泰格醫藥5月19日耗資2958.15萬元回購34.94萬股A股;金斯瑞生物科技尾盤升逾6%,傳奇生物申辦研究的八篇摘要入選2022ASCO等會議。

生物科技板塊暴跌。君實生物跌超12%;亞盛醫藥-B跌超11%;中國再生醫學跌超9%;騰盛博藥-B、中國抗體-B等多股跌超8%。君實生物高開逾5%,VV116新冠口服藥重要臨牀研究達到主要終點;亞盛醫藥高開14.90%,奧雷巴替尼有治療新冠潛力;騰盛博藥-B尾盤再度飆升逾8%,旗下新冠療法已被納入20多個省份的醫保目錄。

醫療設備板塊全線走低。啓明醫療-B跌超10%;微創醫療跌超9%;佳兆業健康、時代天使等多股跌超6%;威高股份跌超5%。

uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.